Jeanette Doorduijn

Dr. Jeanette Doorduijn is a Researcher in the Department of Hematology at Erasmus University Medical Center. Her work focuses on hematological malignancies, particularly primary central nervous system lymphoma (PCNSL) and chronic lymphocytic leukemia (CLL). She has contributed to clinical practice guidelines for PCNSL diagnosis and treatment, and her research includes pharmacokinetic analyses of high-dose methotrexate therapy and population-based mortality studies in CLL patients. Her work spans 107 publications, with recent emphasis on drug toxicity, treatment outcomes, and guideline development.

• Key affiliations: Erasmus MC (Hematology)
• Research interests: Oncology, clinical pharmacology, CNS lymphoma, drug toxicity analysis

Her recent studies examined survival outcomes in PCNSL patients treated with megadose chemotherapy and explored causes of death in CLL populations. She co-authored EHA-ESMO clinical guidelines for PCNSL management, reflecting her role in shaping treatment standards.